Contact us
Mobile menu not yet fully implemented
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
This was 1 year ago
LocationVirtual
ProgrammesThis info day organized by the European Commission aims to inform (potential) applicants about the new topics included in the Widening participation and strengthening the European Research Area (WIDERA) work programme of 2023-2024.
Horizon Europe’s Widening actions support EU countries that lag behind in research and innovation to increase their performance, while ERA actions aim at reforming and enhancing the European research and innovation system overall.
The morning session will focus on the widening part and the afternoon session on the ERA part.
Recording Widening part and ERA part
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Cybersecurity Defence EDF NATO-EDA
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
